Outcomes of Gemcitabine, Vinorelbine, and Doxorubicin in Peripheral T-Cell Lymphoma. acmcr. 2024;8(3):92-96. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22941